Solidus Investment

What Solidus Investment does

Solidus Investment Co., Ltd. (주식회사 솔리더스인베스트먼트) is a Seoul-based venture capital firm founded in June 2011 and registered with Korea's Small and Medium Business Administration. Originally established under the CHA Medical Center Group, the firm underwent a change of major shareholder to JW Holdings (a KOSPI-listed healthcare conglomerate) in 2026 and now operates as its in-house venture arm while continuing to raise third-party capital. It focuses investment activity on Bio/Healthcare, ICT/Electronics, and Agrifood/Bio sectors, deploying capital through a series of Korean-won-denominated funds that range from 4.05 billion won to 150 billion won in size.

The firm manages multiple fund families — KB-Solidus Global Healthcare Fund, IBKC-Solidus Smart-Bio Investment Fund, Solidus Star-Venteur, Solidus Global Agrifood & Bio, and others — typically as co-branded vehicles with institutional partners including KB Financial Group, IBK Financial Group, and Korea Development Bank-affiliated entities. As of the most recent reporting, Solidus reports 100+ portfolio companies spanning BIO/Healthcare, ICT/electrical/electronic, and food/distribution, and has realized three liquidations with disclosed returns of IRR 17%/2.24x (2018), IRR 14.8%/1.9x (2023), and IRR 12.31%/1.65x (2026). In March 2026 it announced the acquisition of Cha Hospital VC for 30.6 billion won, consolidating a peer healthcare-focused manager.

The business model is conventional Korean VC fund management: earning management fees on committed capital across multiple vintages, supplemented by carried interest upon successful exits. Deal sourcing is driven by an advisory committee of academic, legal, financial, and public-institution specialists plus in-house investment professionals with 10+ years of operating and investing experience in food, bio, pharmaceutical, and IT enterprises. The firm runs a lean ~10-person team out of a single Gangnam-gu, Seoul office, and has not publicly disclosed fund terms, fee rates, or financial performance metrics beyond headline IRR/multiple data on liquidated vehicles.

Name

Solidus Investment

Legal name

(주)솔리더스인베스트먼트

Website

https://solidusvc.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Solidus Investment is a Seoul-based venture capital firm (founded 2011, ~10 staff) that manages multiple Bio/Healthcare, ICT, and Agrifood-focused funds — including the KB-Solidus and IBKC-Solidus series — alongside 100+ portfolio companies, and now operates as the venture arm of JW Holdings following a 2026 ownership change.

Ownership category

akta.pro rank

Product category

Venture Capital Fund Management

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Healthcare & Life Sciences Growth Equity (FSANACAB)

akta.pro secondary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Venture capital management
• Biotech investments
• Healthcare investment funds
• Early-stage funding
• Startup investment advisory

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Fund Management: Solidus Investment operates multiple venture capital funds focused on Bio/Healthcare and IT sectors. The firm earns returns through successful portfolio company exits, management fees, and carried interest from fund operations. Key funds include KB-Solidus Global Healthcare Fund (150B won), Solidus Smart-Bio Investment Fund (100B won), and various other sector-specific funds.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Solidus Investment is a Seoul-based venture capital firm that manages multiple sector-focused investment funds, primarily in Bio/Healthcare and IT, providing early-stage capital, strategic guidance, and post-investment support to portfolio companies. The firm raises and operates funds in partnership with major Korean financial institutions (KB Financial Group, IBK Financial Group) and institutional investors, targeting both Korean and international investment opportunities.

Product overview

Solidus Investment is a venture capital firm founded in June 2011 that operates a portfolio of sector-focused investment funds targeting Bio/Healthcare, ICT, and agrifood companies. The firm's main fund series include the KB-Solidus Global Healthcare Fund, Solidus Smart-Bio Investment Fund, Solidus Star-Venteur Investment Fund, Solidus Global Agrifood&Bio Investment Fund, and IBK-SOLIDUS Next Bio Star Investment Fund. These funds range from 4.05 billion won to 150 billion won in size and focus on identifying and investing in promising biotech companies and early-stage ventures with growth potential, primarily in the Korean market. The company also recently acquired Cha Hospital VC for 30.6 billion won and maintains affiliations with JW Holdings and its subsidiary companies in the pharmaceutical and healthcare sectors.

Differentiator

Problem solved

Functional benefit

Products and services

• KB-Solidus Global Healthcare Fund A healthcare-focused venture capital fund managed by Solidus Investment in partnership with KB Financial Group, targeting biotechnology and healthcare companies.
• Solidus Smart-Bio Investment Fund A 100 billion won smart-bio investment fund focused on biotech companies with growth potential in the bio and healthcare sectors.
• Solidus Star-Venteur Investment Fund A venture capital fund series targeting early-stage biotech and bio healthcare companies with strong growth potential.
• Solidus Global Agrifood & Bio Investment Fund A series of agrifood and bio-focused investment funds targeting companies in the agricultural, food, and biotechnology sectors, with Fund No.1 achieving 17% IRR and 2.24x multiple upon liquidation.
• IBK-SOLIDUS Next Bio Star Investment Fund A 23.5 billion won biotech-focused investment fund operated in partnership with IBK (Industrial Bank of Korea) targeting next-generation biotech companies.
• Solidus Growth Ladder Start Up Fund

Quantifiable outcome

• KB-Solidus Global Healthcare Fund No.5 achieved IRR of 12.31% with 1.65x multiple upon liquidation in 2026
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor.

• Korea Venture Capital Association (KVCA)minorOthers · 1 January 2014Solidus Investment is registered with the Small and Medium Business Administration as a venture capital firm (registered July 2011). The firm operates under regulatory oversight and industry association frameworks for venture capital investments in Korea.
• Roche Group / Chugai PharmaceuticalminorStrategic or Co-development Partner · 1 January 1992JW Holdings subsidiary C&C Research Laboratories is a joint venture established with Roche Group and Chugai Pharmaceutical in 1992 for new drug development. This provides indirect strategic connections through the JW Holdings ecosystem that Solidus Investment operates within.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Mirae Asset Venture Investment: One of Korea's largest venture capital firms with a similarly broad portfolio across biotech, IT, and consumer. Comparable in stage focus (early-stage Korean companies), institutional LP structure, and multi-fund franchise model.
• M Venture Investment: Korean venture capital firm investing in biotech, healthcare, and IT startups across multiple fund vintages. Directly comparable to Solidus in sector mix, fund size range, and team-size profile.
• LB Investment: Korean venture capital and growth equity firm with significant biotech and IT exposure. Comparable in early-to-growth stage Korean investments and institutional LP partnerships.
• UTC Investment: Korean VC firm focused on bio/healthcare and technology investments with multiple funds. Comparable sector focus and institutional fund-of-funds partnerships similar to Solidus' KB and IBK collaborations.
• Smilegate Investment: Korean venture capital arm of the Smilegate Group with a focus on bio/healthcare and IT. Comparable in corporate-affiliated VC structure, sector specialization, and team-driven investment approach.
• Capstone Partners (formerly Company K Partners): Korean venture capital firm with biotech and technology focus across multiple fund vintages. Comparable in team scale, fund structure, and Korean bio/healthcare specialization.
• DAESUNG Venture Capital: Korean venture capital firm focused on early-stage Korean companies including biotech and technology. Comparable in stage and sector focus, with similar institutional LP structure.

Broad incumbents

• Korea Investment Partners: Major Korean VC and growth equity firm with extensive healthcare and technology portfolio. Comparable as a large institutional Korean VC with multi-fund structure and similar sector breadth.
• SBI Investment Korea: Korean arm of Japan's SBI Group, operating multiple venture funds in biotech and IT. Comparable as a multi-fund, sector-focused Korean VC with international backing.

Emerging players

• Primer Ventures (formerly Primer): Korean venture capital firm with biotech and deep-tech focus. Comparable in Korean bio/healthcare specialization but typically earlier-stage and smaller fund sizes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments45 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solidus Investment